Author:
Staudigl Christine,Pfeiler Georg,Hrauda Katharina,Renz Romana,Berger Andreas,Lichtenschopf Renate,Singer Christian F.,Tea Muy-Kheng M.
Funder
Teva Pharmaceutical Industries
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference45 articles.
1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.
2. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61(6):409–18.
3. Sardanelli F, Santoro F, Podo F. Screening high risk women with MRI alone? Eur J Radiol. 2013;81 Suppl 1:S137–8.
4. Rosenthal TC, Puck SM. Screening for genetic risk of breast cancer. Am Fam Physician. 1999;59(1):99–104. 6.
5. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006;24(6):863–71.